Latest From Ornim Inc.
By combining near-infrared spectroscopy with ultrasound waves, clinicians now have the ability to noninvasively monitor blood flow changes and oxygen saturation in the brain. The CerOx monitor, from Israel-based Ornim Inc., is a vital organ monitoring device that can simultaneously monitor the brain and other tissue of critical care patients. The company estimates that there are approximately 10 million medical procedures annually that could benefit from CerOx, ranging from patients with traumatic brain injury to occlusive vascular disease.
START-UP's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.
This Month's Profile Group: New Orals, Better Topicals Top Psoriasis Wish List, features profiles of Avexxin, Cellceutix, Convoy Therapeutics, and Creabilis. Plus these Start-Ups Across Health Care: Domain Surgical, Ornim, Protagonist Therapeutics, SpineGuard, and Xcovery.
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
- Diagnostic Equipment & Supplies
Diagnostic Imaging Equipment & Supplies
- Monitoring Equipment & Devices
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Ornim Inc.
- Senior Management
Isreal Schreiber, CEO
Eli Kotzero, CFO
Revital Schechter, PhD, CSO
Gary J Sagiv, VP, Global Mktg. & Sales
- Contact Info
Phone: (866) 811-6384
125 Washington St., #7
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.